Compound Detail
CHEMBL5220791
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CN1CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C2CCCCC2)C(=O)N[C@H](C(N)=O)CCC(=O)N[C@@H](CCCNC(=N)N)C1=O
Basic Information
| ChEMBL ID | CHEMBL5220791 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZCTGDUFMTKKJNM-IAGYGMIVSA-N |
0
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
609.7
MW (Da)
-3.02
ALogP
8
HBA
9
HBD
279.0
PSA (Ų)
0.08
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas.
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33961417 | 10.1021/acs.jmedchem.1c00533 | Integrin alpha-V/beta-6 | 1 |
| 33961417 | 10.1021/acs.jmedchem.1c00533 | Unchecked | 1 |
| 33961417 | 10.1021/acs.jmedchem.1c00533 | Integrin alpha-V/beta-3 | 1 |
| 33961417 | 10.1021/acs.jmedchem.1c00533 | Integrin alpha-5/beta-1 | 1 |
Data from ChEMBL 36 via Core Engine